Supernus Pharmaceuticals Overview
Supernus Pharmaceuticals Target Price
Analysts' 12-month price predictions for SUPN.
Share Price
$46
Average Target Price
$42.00
8.7% downside
8.7% downside1 analysts in the last 4 months
High: $42 | Low: $42
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-07-29 | Cantor Fitzgerald | $42 | 8.7% downside |  |
| 2024-09-11 | Piper SandlerDavid Amsellem | $36 | 21.7% downside | |
| 2024-05-24 | Piper SandlerDavid Amsellem | $41 | 10.9% downside | |
| 2024-04-08 | JefferiesIrene Buhalo | $40 | 13% downside | |
| 2024-04-08 | Stifel NicolausAnnabel Samimy | $38 | 17.4% downside | |